128 related articles for article (PubMed ID: 35894087)
1. SNAI2 promotes the malignant transformation of oral leukoplakia by modulating p-EMT.
Shang Q; Peng J; Jiang Y; Qing M; Zhou Y; Xu H; Chen Q
Oral Dis; 2023 Nov; 29(8):3232-3242. PubMed ID: 35894087
[TBL] [Abstract][Full Text] [Related]
2. microRNA-33a prevents epithelial-mesenchymal transition, invasion, and metastasis of gastric cancer cells through the Snail/Slug pathway.
Chen DD; Cheng JT; Chandoo A; Sun XW; Zhang L; Lu MD; Sun WJ; Huang YP
Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G147-G160. PubMed ID: 30943047
[TBL] [Abstract][Full Text] [Related]
3. Snail and Axin2 expression predict the malignant transformation of oral leukoplakia.
Zhang X; Kim KY; Zheng Z; Kim HS; Cha IH; Yook JI
Oral Oncol; 2017 Oct; 73():48-55. PubMed ID: 28939076
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive bioinformatics analysis combined with experimental validation to screen biomarkers for malignant transformation of oral leukoplakia.
Li F; Qiu L; Gao Q; Yu L; Liu H; Xue Z; Tao A
Genomics; 2023 Sep; 115(5):110686. PubMed ID: 37454941
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA expression profiling and functional annotation analysis of their targets associated with the malignant transformation of oral leukoplakia.
Maimaiti A; Abudoukeremu K; Tie L; Pan Y; Li X
Gene; 2015 Mar; 558(2):271-7. PubMed ID: 25576219
[TBL] [Abstract][Full Text] [Related]
6. lncRNA AC005224.4/miR-140-3p/SNAI2 regulating axis facilitates the invasion and metastasis of ovarian cancer through epithelial-mesenchymal transition.
Xiong T; Wang Y; Zhang Y; Yuan J; Zhu C; Jiang W
Chin Med J (Engl); 2023 May; 136(9):1098-1110. PubMed ID: 36939239
[TBL] [Abstract][Full Text] [Related]
7. Malignant transformation of oral leukoplakia treated with carbon dioxide laser: a meta-analysis.
Dong Y; Chen Y; Tao Y; Hao Y; Jiang L; Dan H; Zeng X; Chen Q; Zhou Y
Lasers Med Sci; 2019 Feb; 34(1):209-221. PubMed ID: 30443884
[TBL] [Abstract][Full Text] [Related]
8. The epithelial-mesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasion.
Fenouille N; Tichet M; Dufies M; Pottier A; Mogha A; Soo JK; Rocchi S; Mallavialle A; Galibert MD; Khammari A; Lacour JP; Ballotti R; Deckert M; Tartare-Deckert S
PLoS One; 2012; 7(7):e40378. PubMed ID: 22911700
[TBL] [Abstract][Full Text] [Related]
9. Sphingosine 1-phosphate signaling induces SNAI2 expression to promote cell invasion in breast cancer cells.
Wang W; Hind T; Lam BWS; Herr DR
FASEB J; 2019 Jun; 33(6):7180-7191. PubMed ID: 30844311
[TBL] [Abstract][Full Text] [Related]
10. Cucurbitacin B induces ferroptosis in oral leukoplakia via the SLC7A11/mitochondrial oxidative stress pathway.
Yang M; Chen X; Cheng C; Yan W; Guo R; Wang Y; Zhang H; Chai J; Cheng Y; Zhang F
Phytomedicine; 2024 Jul; 129():155548. PubMed ID: 38583347
[TBL] [Abstract][Full Text] [Related]
11. SNAI2 upregulation is associated with an aggressive phenotype in fulvestrant-resistant breast cancer cells and is an indicator of poor response to endocrine therapy in estrogen receptor-positive metastatic breast cancer.
Alves CL; Elias D; Lyng MB; Bak M; Ditzel HJ
Breast Cancer Res; 2018 Jun; 20(1):60. PubMed ID: 29921289
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of miR-31* is negatively associated with recurrent/newly formed oral leukoplakia.
Xiao W; Bao ZX; Zhang CY; Zhang XY; Shi LJ; Zhou ZT; Jiang WW
PLoS One; 2012; 7(6):e38648. PubMed ID: 22719913
[TBL] [Abstract][Full Text] [Related]
13. Association between hyperglycemia and the malignant transformation of oral leukoplakia in China.
Li J; Liu Y; Zhang H; Hua H
Oral Dis; 2020 Oct; 26(7):1402-1413. PubMed ID: 32348606
[TBL] [Abstract][Full Text] [Related]
14. A novel lncRNA LOLA1 may predict malignant progression and promote migration, invasion, and EMT of oral leukoplakia via the AKT/GSK-3β pathway.
Liu W; Yao Y; Shi L; Tang G; Wu L
J Cell Biochem; 2021 Oct; 122(10):1302-1312. PubMed ID: 33969929
[TBL] [Abstract][Full Text] [Related]
15. SNAI2 is induced by transforming growth factor-β1, but is not essential for epithelial-mesenchymal transition in human keratinocyte HaCaT cells.
Miyake Y; Nagaoka Y; Okamura K; Takeishi Y; Tamaoki S; Hatta M
Exp Ther Med; 2021 Oct; 22(4):1124. PubMed ID: 34466140
[TBL] [Abstract][Full Text] [Related]
16. ΔNp63γ/SRC/Slug Signaling Axis Promotes Epithelial-to-Mesenchymal Transition in Squamous Cancers.
Srivastava K; Pickard A; Craig SG; Quinn GP; Lambe SM; James JA; McDade SS; McCance DJ
Clin Cancer Res; 2018 Aug; 24(16):3917-3927. PubMed ID: 29739791
[No Abstract] [Full Text] [Related]
17. EGR1 induces EMT in pancreatic cancer via a P300/SNAI2 pathway.
Wang Y; Qin C; Zhao B; Li Z; Li T; Yang X; Zhao Y; Wang W
J Transl Med; 2023 Mar; 21(1):201. PubMed ID: 36932397
[TBL] [Abstract][Full Text] [Related]
18. Negative feedback by SNAI2 regulates TGFβ1-induced amelotin gene transcription in epithelial-mesenchymal transition.
Nakayama Y; Tsuruya Y; Noda K; Yamazaki-Takai M; Iwai Y; Ganss B; Ogata Y
J Cell Physiol; 2019 Jul; 234(7):11474-11489. PubMed ID: 30488439
[TBL] [Abstract][Full Text] [Related]
19. Molecular regulation of Snai2 in development and disease.
Zhou W; Gross KM; Kuperwasser C
J Cell Sci; 2019 Dec; 132(23):. PubMed ID: 31792043
[TBL] [Abstract][Full Text] [Related]
20. FSCN1 is upregulated by SNAI2 and promotes epithelial to mesenchymal transition in head and neck squamous cell carcinoma.
Wang L; Jia Y; Jiang Z; Gao W; Wang B
Cell Biol Int; 2017 Aug; 41(8):833-841. PubMed ID: 28488774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
